Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-dose Tegilidine vs sufentanil for postoperative analgesia in elderly laparoscopic surgery
ChiCTR2500100070Phase 4Not yet recruiting
- Sponsor
- Chengdu Jinniu District People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tegilidine in postoperative pain (2 arms), sponsored by Chengdu Jinniu District People's Hospital. Primary endpoints: Static and dynamic VAS pain scores and Occurrence of adverse events. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
Tegilidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500100070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100070.